Belsomra and Potassium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Belsomra (suvorexant) and Potassium (potassium). Common drug interactions include muscle spasms among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Belsomra and Potassium. It is created by eHealthMe based on reports of 81 people who take the same drugs from the FDA, and is updated regularly.

What is Belsomra?

Belsomra has active ingredients of suvorexant. It is often used in insomnia. eHealthMe is studying from 12,961 Belsomra users. Check the latest studies of Belsomra.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,148 Potassium users. Check the latest studies of Potassium.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

81 people who take Belsomra and Potassium together, and have interactions are studied.

Belsomra and Potassium drug interactions.

What are the common drug interactions of Belsomra and Potassium, by gender? *:

female:

Muscle spasms (muscle contraction)
Nasopharyngitis (inflammation of the nasopharynx)
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Rash
Tibia fracture (fracture of lower leg bone)
Agitation (state of anxiety or nervous excitement)
Alanine aminotransferase increased
Aphasia (damage to the parts of the brain that control language)
Aspartate aminotransferase increased
Balance disorder

male:

Dyspnoea (difficult or laboured respiration)
Hallucination (an experience involving the perception of something not present)
Prostatic disorder
Pruritus (severe itching of the skin)
Renal pain (kidney pain)
Weight decreased
Anuria (failure of the kidneys to produce urine)
Arthropathy
Asthenia (weakness)
Back disorder

What are the common drug interactions of Belsomra and Potassium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Mania (a state of abnormally elevated or irritable mood)
Pericardial effusion (fluid around the heart)
Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)

40-49:

Road traffic accident
Drug ineffective
Headache (pain in head)
Injury
Migraine (headache)
Pain
Weight decreased
Arthrodesis
Bone disorder
Chronic kidney disease

50-59:

Nausea (feeling of having an urge to vomit)
Oedema peripheral (superficial swelling)
Pain in extremity
Upper respiratory tract infection
Hypotension (abnormally low blood pressure)
Abscess limb (limb infection)
Adverse drug reaction
Anal abscess
Bladder cancer
Bladder cancer recurrent

60+:

Herpes zoster
Migraine (headache)
Hallucination (an experience involving the perception of something not present)
Infection
Infusion site haemorrhage (bleeding from infusion site)
Localised infection (infection at the single location)
Nightmare (unpleasant dream)
Pneumonia
Sinusitis (inflammation of sinus)
Balance disorder

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 20 people, 24.69%
High Blood Pressure: 9 people, 11.11%
Pain: 9 people, 11.11%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 9.88%
Fibromyalgia (a long-term condition which causes pain all over the body): 8 people, 9.88%
Immunodeficiency Common Variable: 7 people, 8.64%
Asthma: 7 people, 8.64%
Multiple Myeloma (cancer of the plasma cells): 7 people, 8.64%
Infection: 6 people, 7.41%
Sleep Disorder: 6 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Belsomra and Potassium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously